Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
Aim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery b...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2018-11-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2921 |
_version_ | 1797856851268730880 |
---|---|
author | A. O. Rubanenko O. A. Rubanenko L. V. Limareva Iu. V. Shchukin |
author_facet | A. O. Rubanenko O. A. Rubanenko L. V. Limareva Iu. V. Shchukin |
author_sort | A. O. Rubanenko |
collection | DOAJ |
description | Aim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery bypass graft (CABG) surgery.Material and methods. Studied were 80 patients who underwent CABG in 2015-2016 years. In all the patients routine laboratory and instrumental tests were performed. Patients also underwent genetic polymorphisms of ММР-9 А8202G and TIMP-1 C536T estimation with polymerase chain reaction. According to occurrence of postoperative atrial fibrillation (POAF) all the patients were divided into two groups: 1 group comprised 56 patients without POAF (81,8% males, mean age 65,9±4,0 years), 2 group — 24 patients with first detected episode of AF after CABG (875% males, mean age 67,7±5,4).Results. According to results of multivariate regression analysis the odds ratio of POAF development in patients with stable angina grade III was 1,8 (95% CI 0,5-75, p=0,4), NYHA III — 0,85 (95% CI 0,2-3,5, p=0,55), history of CAD more than 20 months — 1,8 (95% CI 1,2-8,1, p=0,03), LA diameter more than 39 mm — 4,2 (95% CI 1,6-9,5, p<0,0001), allele G MMP-9 A8202G — 2,6 (95% CI 1,2-75, p=0,03). Conclusion. In elderly patients undergoing coronary artery bypass graft surgery left atrial diameter more than 39 mm, history of coronary artery disease more than 20 months and the presence of G allele of MMP-9 A820G are significantly associated with postoperative atrial fibrillation occurrence. |
first_indexed | 2024-04-09T20:47:07Z |
format | Article |
id | doaj.art-effe3d879f8340f0af487ceb57e2f716 |
institution | Directory Open Access Journal |
issn | 1560-4071 2618-7620 |
language | Russian |
last_indexed | 2024-04-09T20:47:07Z |
publishDate | 2018-11-01 |
publisher | «FIRMA «SILICEA» LLC |
record_format | Article |
series | Российский кардиологический журнал |
spelling | doaj.art-effe3d879f8340f0af487ceb57e2f7162023-03-29T21:23:31Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202018-11-01010485210.15829/1560-4071-2018-10-48-522511Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patientsA. O. Rubanenko0O. A. Rubanenko1L. V. Limareva2Iu. V. Shchukin3Samara state medical universitySamara state medical universitySamara state medical universitySamara state medical universityAim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery bypass graft (CABG) surgery.Material and methods. Studied were 80 patients who underwent CABG in 2015-2016 years. In all the patients routine laboratory and instrumental tests were performed. Patients also underwent genetic polymorphisms of ММР-9 А8202G and TIMP-1 C536T estimation with polymerase chain reaction. According to occurrence of postoperative atrial fibrillation (POAF) all the patients were divided into two groups: 1 group comprised 56 patients without POAF (81,8% males, mean age 65,9±4,0 years), 2 group — 24 patients with first detected episode of AF after CABG (875% males, mean age 67,7±5,4).Results. According to results of multivariate regression analysis the odds ratio of POAF development in patients with stable angina grade III was 1,8 (95% CI 0,5-75, p=0,4), NYHA III — 0,85 (95% CI 0,2-3,5, p=0,55), history of CAD more than 20 months — 1,8 (95% CI 1,2-8,1, p=0,03), LA diameter more than 39 mm — 4,2 (95% CI 1,6-9,5, p<0,0001), allele G MMP-9 A8202G — 2,6 (95% CI 1,2-75, p=0,03). Conclusion. In elderly patients undergoing coronary artery bypass graft surgery left atrial diameter more than 39 mm, history of coronary artery disease more than 20 months and the presence of G allele of MMP-9 A820G are significantly associated with postoperative atrial fibrillation occurrence.https://russjcardiol.elpub.ru/jour/article/view/2921elderly patientsatrial fibrillationcoronary artery bypass graftgenetic polymorphismsmatrix metalloproteinase-9tissue inhibitor of matrix metalloproteinase-1 |
spellingShingle | A. O. Rubanenko O. A. Rubanenko L. V. Limareva Iu. V. Shchukin Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients Российский кардиологический журнал elderly patients atrial fibrillation coronary artery bypass graft genetic polymorphisms matrix metalloproteinase-9 tissue inhibitor of matrix metalloproteinase-1 |
title | Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients |
title_full | Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients |
title_fullStr | Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients |
title_full_unstemmed | Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients |
title_short | Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients |
title_sort | genetic polymorphisms of matrix metalloproteinase 9 tissue inhibitor of matrix metalloproteinase 1 and development of postoperative atrial fibrillation in elderly patients |
topic | elderly patients atrial fibrillation coronary artery bypass graft genetic polymorphisms matrix metalloproteinase-9 tissue inhibitor of matrix metalloproteinase-1 |
url | https://russjcardiol.elpub.ru/jour/article/view/2921 |
work_keys_str_mv | AT aorubanenko geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients AT oarubanenko geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients AT lvlimareva geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients AT iuvshchukin geneticpolymorphismsofmatrixmetalloproteinase9tissueinhibitorofmatrixmetalloproteinase1anddevelopmentofpostoperativeatrialfibrillationinelderlypatients |